A large scale review of self-monitoring of blood glucose (SMBG) reveals that newly diagnosed patients with type 2 diabetes, who are not on insulin, are achieving significantly better HbA1c values if they have access to blood glucose testing supplies.
The less positive news is that the study showed HbA1c improvement to not continue bringing significant benefits for periods over a year, and this is the message that has been conveyed to health professionals through the media.
The Cochrane review is a review of previously run studies, across a number of different countries, which have analysed self monitoring and its effect on HbA1c levels. People with type 2 diabetes have previously noted the various limitations of the studies included in the review. Studies, included in the Cochrane review, have notably excluded participants who had previously demonstrated interest in self monitoring.
Editor of leading diabetes community website Diabetes.co.uk, Benedict Jephcote states: "There are a number of problems with the way results are presented within the Cochrane review. For instance, in the UK, there are many people with type 2 diabetes that are actively interested in self-testing and significant numbers of these people have to buy test strips from their own income. Studies which exclude these people cannot therefore give a fair representation of people with type 2 diabetes in the UK."
Self-monitoring achieves significant benefit for newly diagnosed diabetics
Mon, 20 Feb 2012
Your comments may be moderated. Please report any spam, illegal, offensive or libellous posts.
Also related to this storyAccess to blood glucose test strips
Diabetes test strips
Diabetes.co.uk test strips petition
Guide for newly diagnosed diabetics
Diabetes and HbA1c
Self Monitoring of Blood Glucose
Newly diagnosed with diabetes
Type 2 Diabetes
Continuous glucose monitoring
Clinical trials and diabetes
Diabetes in India
Periodontal blood samples can help diabetes screening
Bold new avenue for type 1 diabetes research
New diabetes management system is trialled
New study into diabetes risk from packaging compound
Diabetes expert appointed Chief Scientist for Scotland
Autoimmune study could lead to diabetes breakthrough
UK universities lead new diabetes prevention programme
Metformin recommended as first drug of choice for type 2 diabetes
Risk of birth defects rises dramatically with diabetes
New research into fundamental causes of diabetes
Bacteria that causes ulcers could increase risk of diabetes
Diabetes combination drugs receive approval in the US
Antipsychotic drugs can lead to diabetes according to research
Diabetic complications the greatest health cost for diabetes
Less deep sleep for children with diabetes worsens their condition
Processed meats increase risk of diabetes for native Americans
Diabetes drugs effect chances of pancreatic cancer, says new study
Scientists identify possible diabetes biomarkers